[Dihydropyridines, a new group of strongly effective coronary therapeutic agents].

Suppr

超能文献

作者信息

Bossert F, Vater W

出版信息

Naturwissenschaften. 1971 Nov;58(11):578. doi: 10.1007/BF00598745.

DOI:10.1007/BF00598745

PMID:5139301

Abstract

摘要

相似文献

[Dihydropyridines, a new group of strongly effective coronary therapeutic agents].

Naturwissenschaften. 1971 Nov;58(11):578. doi: 10.1007/BF00598745.

Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.

Arzneimittelforschung. 1972 Feb;22(2):344-9.

Systemic and coronary hemodynamic effects of sodium nitroprusside.

Am Heart J. 1974 Jan;87(1):83-7. doi: 10.1016/0002-8703(74)90394-9.

Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation.

J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):630-6. doi: 10.1097/00005344-198507000-00003.

[Influence of some vasodilator agents on coronary flow].

Boll Soc Ital Cardiol. 1970;15(5):388-401.

[Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].

Arzneimittelforschung. 1972 Jan;22(1):33-9.

Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.

Arzneimittelforschung. 1972 Mar;22(3):502-7.

Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs.

Circulation. 1982 Sep;66(3):579-88. doi: 10.1161/01.cir.66.3.579.

[Active vasomotor reactions of the coronary vessels during the action of certain humoral stimuli].

Kardiologiia. 1973 May;13(5):100-4.

[The mechanism of coronary dilatating action of nifedipine].

Arzneimittelforschung. 1972 Jan;22(1):39-42.

引用本文的文献

Identification of a dihydropyridine scaffold that blocks ryanodine receptors.

iScience. 2021 Dec 27;25(1):103706. doi: 10.1016/j.isci.2021.103706. eCollection 2022 Jan 21.

5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activities.

Mol Divers. 2019 May;23(2):471-508. doi: 10.1007/s11030-018-9886-4. Epub 2018 Nov 2.

1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.

Transl Med UniSa. 2012 Oct 11;4:12-26. Print 2012 Sep.

Vascular effects of calcium channel antagonists: new evidence.

Drugs. 2005;65 Suppl 2:1-10. doi: 10.2165/00003495-200565002-00002.

Decoration of dihydropyrimidine and dihydropyridine scaffolds with sugars via Biginelli and Hantzsch multicomponent reactions: an efficient entry to a collection of artificial nucleosides.

Mol Divers. 2003;6(3-4):261-70. doi: 10.1023/b:modi.0000006806.91483.a3.

Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation.

Ann Surg. 1981 Jun;193(6):719-32. doi: 10.1097/00000658-198106000-00007.

Properties of a new calcium ion antagonist on cellular uptake and mitochondrial efflux of calcium ions.

Biochem J. 1984 Mar 15;218(3):899-905. doi: 10.1042/bj2180899.

Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.

Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):73-8. doi: 10.1007/BF03189607.

Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.

Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):382-7. doi: 10.1007/BF00692905.

Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension.

Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:319-25. doi: 10.1007/BF00148477.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验